Sign Up Today and Learn More About MimiVax Stock
Invest in or calculate the value of your shares in MimiVax or other pre-IPO companies through EquityZen's platform.
MimiVax Stock (MIMI)
MimiVax is a developer of immunotherapeutic vaccines and targeted therapies used to control tumor growth and recurrence.
About MimiVax Stock
Founded
2012
Headquarters
Buffalo, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
MimiVax Press Mentions
Stay in the know about the latest news on MimiVax
Inno Madness 2025 has begun. Which of these 32 companies gets your vote?
bizjournals • Apr 21, 2025
MimiVax Announces Positive Interim Analysis in Ongoing SurVaxM Clinical Trial
prnewswire • Feb 13, 2025
MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment
prnewswire • Jan 10, 2025
US FDA awards Supplemental Orphan Drug Designation to SurVaxM to now include treatment of Malignant Glioma
prnewswire • Aug 03, 2024
Biotech firm raises $5.8M for cancer drug trial - Buffalo Business First
bizjournals • Jul 24, 2024
MimiVax Management
Leadership team at MimiVax
Board Member, Co-founder, and General Counsel
Scott E. Friedman
Chief Medical Officer
Robert Fenstermaker
Join now and verify your accreditation status to gain access to:
- MimiVax Current Valuation
- MimiVax Stock Price
- MimiVax Management
- Available deals in MimiVax and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- MimiVax Cap Table and Funding History by Share Class and Liquidity Preferences
- MimiVax Revenue and Financials
- MimiVax Highlights
- MimiVax Business Model
- MimiVax Risk Factors
- MimiVax Research Report from SACRA Research
Trading MimiVax Stock
How to invest in MimiVax stock?
Accredited investors can buy pre-IPO stock in companies like MimiVax through EquityZen funds. These investments are made available by existing MimiVax shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell MimiVax stock?
Shareholders can sell their MimiVax stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
